(NA) Nano Labs - Ratings and Ratios
Semiconductor Chips, SoC Design, ASIC Services
NA EPS (Earnings per Share)
NA Revenue
Description: NA Nano Labs
Nano Labs Ltd is a fabless integrated circuit design company that develops computing chips, application specific integrated circuit chips, smart network interface cards, and vision computing chips. The company also engages in software research and development, catering to enterprises and individual buyers across various regions, including China, Hong Kong, Singapore, and the United States.
As a semiconductor company, Nano Labs Ltd operates in a highly competitive and rapidly evolving industry. To assess its performance, key performance indicators (KPIs) such as revenue growth rate, gross margin, and research and development (R&D) expenditure as a percentage of revenue are crucial. A high R&D expenditure is expected in this industry, and a rising revenue growth rate could indicate successful product development and market penetration.
With a market capitalization of $197.53 million, Nano Labs Ltd is a relatively small-cap company. The absence of a price-to-earnings (P/E) ratio and forward P/E ratio suggests that the company is currently unprofitable, which is further reinforced by the negative return on equity (RoE) of -164.45%. This indicates that the company is still in its growth phase and may require continued investment to achieve profitability.
To evaluate the companys potential, its essential to monitor its progress in developing and commercializing new products, expanding its customer base, and improving its financial performance. Key metrics to watch include the companys burn rate, cash reserves, and projected time to profitability. A thorough analysis of these factors will help determine whether Nano Labs Ltd is an attractive investment opportunity.
NA Stock Overview
| Market Cap in USD | 112m |
| Sub-Industry | Semiconductors |
| IPO / Inception | 2022-07-12 |
NA Stock Ratings
| Growth Rating | -40.7% |
| Fundamental | 22.4% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 36.1% |
| Analyst Rating | - |
NA Dividends
Currently no dividends paidNA Growth Ratios
| Growth Correlation 3m | -76.2% |
| Growth Correlation 12m | -14.7% |
| Growth Correlation 5y | -70.5% |
| CAGR 5y | -53.73% |
| CAGR/Max DD 3y | -0.57 |
| CAGR/Mean DD 3y | -0.69 |
| Sharpe Ratio 12m | -1.14 |
| Alpha | 0.33 |
| Beta | 0.712 |
| Volatility | 101.11% |
| Current Volume | 142.4k |
| Average Volume 20d | 189.8k |
| Stop Loss | 4.5 (-8.5%) |
| Signal | -0.84 |
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income (-184.4m TTM) > 0 and > 6% of Revenue (6% = 3.83m TTM) |
| FCFTA -0.29 (>2.0%) and ΔFCFTA 36.96pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 246.0% (prev -14.80%; Δ 260.8pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.20 (>3.0%) and CFO -126.2m > Net Income -184.4m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (NaN) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin -33.35% (prev 13.49%; Δ -46.84pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 13.03% (prev 224.5%; Δ -211.5pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -100.0k (EBITDA TTM -153.2m / Interest Expense TTM 936.8) >= 6 (WARN >= 3) |
Altman Z'' -5.00
| (A) 0.26 = (Total Current Assets 366.6m - Total Current Liabilities 209.4m) / Total Assets 615.9m |
| (B) -0.92 = Retained Earnings (Balance) -565.2m / Total Assets 615.9m |
| (C) -0.32 = EBIT TTM -158.7m / Avg Total Assets 490.4m |
| (D) -1.44 = Book Value of Equity -549.7m / Total Liabilities 383.0m |
| Total Rating: -5.00 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 22.39
| 1. Piotroski 0.50pt = -4.50 |
| 2. FCF Yield -24.29% = -5.0 |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.86 = 2.14 |
| 5. Debt/Ebitda -1.30 = -2.50 |
| 6. ROIC - WACC (= -67.23)% = -12.50 |
| 7. RoE -164.5% = -2.50 |
| 8. Rev. Trend -8.03% = -0.60 |
| 9. EPS Trend -42.99% = -2.15 |
What is the price of NA shares?
Over the past week, the price has changed by +1.23%, over one month by -3.53%, over three months by -50.00% and over the past year by +61.31%.
Is Nano Labs a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NA is around 3.53 USD . This means that NA is currently overvalued and has a potential downside of -28.25%.
Is NA a buy, sell or hold?
What are the forecasts/targets for the NA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 3.9 | -20.9% |
Last update: 2025-09-13 04:38
NA Fundamental Data Overview
CCE Cash And Equivalents = 275.3m CNY (Cash And Short Term Investments, last quarter)
P/S = 4.6541
P/B = 1.2886
Beta = None
Revenue TTM = 63.9m CNY
EBIT TTM = -158.7m CNY
EBITDA TTM = -153.2m CNY
Long Term Debt = 173.6m CNY (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 25.3m CNY (from shortTermDebt, last quarter)
Debt = 198.9m CNY (Calculated: Short Term 25.3m + Long Term 173.6m)
Net Debt = 166.4m CNY (from netDebt column, last quarter)
Enterprise Value = 723.4m CNY (799.8m + Debt 198.9m - CCE 275.3m)
Interest Coverage Ratio = -169.4k (Ebit TTM -158.7m / Interest Expense TTM 936.8)
FCF Yield = -24.29% (FCF TTM -175.7m / Enterprise Value 723.4m)
FCF Margin = -274.9% (FCF TTM -175.7m / Revenue TTM 63.9m)
Net Margin = -288.6% (Net Income TTM -184.4m / Revenue TTM 63.9m)
Gross Margin = -33.35% ((Revenue TTM 63.9m - Cost of Revenue TTM 85.2m) / Revenue TTM)
Tobins Q-Ratio = -1.32 (set to none) (Enterprise Value 723.4m / Book Value Of Equity -549.7m)
Interest Expense / Debt = 0.00% (Interest Expense 936.8 / Debt 198.9m)
Taxrate = 21.0% (US default)
NOPAT = -158.7m (EBIT -158.7m, no tax applied on loss)
Current Ratio = 1.75 (Total Current Assets 366.6m / Total Current Liabilities 209.4m)
Debt / Equity = 0.86 (Debt 198.9m / last Quarter total Stockholder Equity 230.8m)
Debt / EBITDA = -1.30 (Net Debt 166.4m / EBITDA -153.2m)
Debt / FCF = -1.13 (Debt 198.9m / FCF TTM -175.7m)
Total Stockholder Equity = 112.1m (last 4 quarters mean)
RoA = -29.94% (Net Income -184.4m, Total Assets 615.9m )
RoE = -164.5% (Net Income TTM -184.4m / Total Stockholder Equity 112.1m)
RoCE = -55.54% (Ebit -158.7m / (Equity 112.1m + L.T.Debt 173.6m))
RoIC = -60.31% (NOPAT -158.7m / Invested Capital 263.1m)
WACC = 6.92% (E(799.8m)/V(998.7m) * Re(8.64%)) + (D(198.9m)/V(998.7m) * Rd(0.00%) * (1-Tc(0.21)))
Shares Correlation 3-Years: 11.03 | Cagr: -10.32%
Discount Rate = 8.64% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -175.7m)
EPS Correlation: -42.99 | EPS CAGR: -21.70% | SUE: N/A | # QB: 0
Revenue Correlation: -8.03 | Revenue CAGR: 2.97% | SUE: N/A | # QB: 0
Additional Sources for NA Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle